期刊文献+

头孢克肟治疗轻中度社区获得性肺炎患儿临床疗效评价及不良反应探讨 被引量:2

Evaluation of Clinical Efficacy and Adverse Reaction of Cefixime in Patients With Mild to Moderate Community Acquired Pneumonia
下载PDF
导出
摘要 目的 探索头孢克肟治疗轻中度社区获得性肺炎患儿的临床疗效。方法 选取我院在2013年12月~2015年12月收治的140例轻中度社区获得性肺炎患儿,进行动态随机化分为两组(观察组和对照组),每组各有70例患儿,对照组采用阿莫西林治疗,观察组采用头孢克肟治疗。结果 观察组患儿的临床症状恢复时间、不良反应发生率、总有效率优于对照组(P〈0.05)。结论 头孢克肟治疗轻中度社区获得性肺炎患儿效果显著,且用药安全性较高。 Objective Cefixime treatment of children with community-acquired pneumonia curative effect. Methods Chose 140 cases from December 2013 to December 2015,divided into two groups(observation group)and control group,70 cases in each group,control group adopts amoxicil in, observation group with cefixime. Results Observation group with the clinical symptoms of recovery time,the incidence of adverse reactions,the total effective rate significantly better than the control group(P < 0.05). Conclusion Cefixime in the treatment of mild to moderate community acquired pneumonia in children with significant effect and high safety for medication.
出处 《中国卫生标准管理》 2016年第12期114-115,共2页 China Health Standard Management
关键词 头孢克肟 轻中度社区获得性肺炎 临床疗效 不良反应 Cefixime Mild to moderate community-acquired pneumonia Clinical curative effect Adverse reaction
  • 相关文献

参考文献3

二级参考文献23

  • 1陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:605
  • 2靳秀红.头孢菌素序贯治疗儿童支气管肺炎疗效观察[J].中国药师,2007,10(4):369-370. 被引量:5
  • 3李成玲,赵瑞芹.儿科常见用药误区解析[M].北京:中国医药科技出版社,2010:71-72.
  • 4Moulin F,Raymond J,Lorrot M. Procalcitonin in children admitted to hospital with community acquired pneumonia[J].Archives of Disease in Childhood,2001,(04):332-336.doi:10.1136/adc.84.4.332.
  • 5Reinhart K,Meisner M,Brunkhorst FM. Markers for sepsis diagnosis:what is useful[J].Critical Care Clinics,2006,(03):503-519.
  • 6Sectish T,Prober CG. Pneumonia.Nelson textbook of pediatrics[M].Philadelphia:WB Saunders,2007.1795-1800.
  • 7Simon L,Gauvin F,Amre DK. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection:a systematic review and meta-analysis[J].Clinical Infectious Diseases,2004,(02):206-217.
  • 8Müller B,Becker KL. Procalcitonin:how a hormone became a marker and mediator of sepsis[J].Swiss Medical Weekly,2001,(41-42):595-602.
  • 9Korppi M,Remes S,Heiskanen-Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children:a negative result in primary healthcare settings[J].Pediatric Pulmonology,2003,(01):56-61.
  • 10Korppi M,Remes S. Serum procalcitonin in pneumococcal pneumonia in children[J].European Respiratory Journal,2001,(04):623-627.

共引文献81

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部